Abiopharma

Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1

Extension of the validity of a shelf prospectus from July 18, 2024 to July 18, 2027

Formation of Treasury Shares in the Issued Share Capital of Phoenix Financial Ltd.

Formation of Treasury Shares in the Issued Share Capital of Phoenix Financial

Formation of Treasury Shares in the Issued Share Capital of Phoenix Financial Ltd.

Amended report for a conference call to review financial statements as of 30.6.26 on 4.8.26 at 9:30, the statements will be published shortly before the conference call is held - typing error

Maalot affirmed a rating of ‘-ilAA’, the outlook is stable

Conference call to review financial statements as of June 30, 2026, on August 4, 2026 at 9:30; the statements will be published shortly before the conference call is held.

Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress

13D-L.I.A. Pure Capital. Ltd, Kfir Silberman, Invest Pro Shukai Hon Ltd, Ron Yair Pelrd

Amended report to the register of shareholders, changes and capital status – exercise of employee warrants – clerical error

FORM N-2-REGISTRATION STATEMENT-POST-EFFECTIVE AMENDMENT NO. 18

Completion of the structural change process and listing for trading of Leviathan override royalty

All of the company’s shares were distributed as a stock dividend to the shareholders of Delek Group.

Change in holdings of interested parties/officers - Shlomo Khoury